Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis
Open Access
- 1 April 2005
- journal article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 46 (4), 623-627
- https://doi.org/10.1194/jlr.c400018-jlr200
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsisNature Medicine, 2004
- Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanismsJournal of Leukocyte Biology, 2004
- Bench to Bedside: HMGB1—A Novel Proinflammatory Cytokine and Potential Therapeutic Target for Septic Patients in the Emergency DepartmentAcademic Emergency Medicine, 2004
- Lipid unites disparate syndromes of sepsisNature Medicine, 2004
- Therapeutic effects of lysophosphatidylcholine in experimental sepsisNature Medicine, 2004
- Release of chromatin protein HMGB1 by necrotic cells triggers inflammationNature, 2002
- IMMUNE DYSFUNCTION IN MURINE POLYMICROBIAL SEPSISShock, 1996
- Human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndromeCritical Care Medicine, 1994
- Adoptive immunotherapy of Gram-negative sepsisCritical Care Medicine, 1993
- Specific Recognition of Cruciform DNA by Nuclear Protein HMG1Science, 1989